Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

NCT00922480 ·Status: COMPLETED ·Phase: PHASE3

Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients

NCT00923611 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers

NCT01146938 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan

NCT02620306 ·Status: COMPLETED ·Phase: PHASE3

A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension

NCT01878201 ·Status: COMPLETED ·Phase: PHASE2

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension

NCT01672476 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)

NCT00937651 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers

NCT01148368 ·Status: COMPLETED ·Phase: PHASE1

Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers

NCT00937534 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion

NCT02022774 ·Status: COMPLETED

Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

NCT02176850 ·Status: COMPLETED

A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers

NCT00938132 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy

NCT01258673 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

NCT02222480 ·Status: COMPLETED ·Phase: PHASE2

Pharmacovigilance and Patient Compliance in Hypertensive Patients

NCT02200575 ·Status: COMPLETED

Candesartan Effect in Second Stage Arterial Hypertension

NCT00621153 ·Status: COMPLETED ·Phase: PHASE4

Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG

NCT03219632 ·Status: COMPLETED

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

NCT01289886 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers

NCT03250052 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension

NCT02466490 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

NCT00775814 ·Status: COMPLETED ·Phase: PHASE4

Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

NCT01289899 ·Status: COMPLETED ·Phase: PHASE1

Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)

NCT00348686 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy

NCT05878561 ·Status: COMPLETED ·Phase: PHASE3

A Trial of Fimasartan for Early Diastolic Heart Failure

NCT01691118 ·Status: COMPLETED ·Phase: PHASE4